Back to results
US 2018/0021317 A1Published application
Pharmaceutical composition for preventing or treating cancer and method using thereof
AssigneeMedpacto Inc.
InventorIl Ho HA
Life of this patent
Estimating the term…
Abstract
Provided are a pharmaceutical composition for preventing or treating cancer and a method of preventing or treating cancer using the same. Cancer may be effectively prevented or treated using the pharmaceutical composition and method.
Claims18
1-14. (canceled)
A method of preventing or treating cancer, the method comprising administering a compound represented by Formula I, a pharmaceutically acceptable salt, solvate, or stereoisomer thereof, or a combination thereof and a T lymphocyte activating factor to a subject:
- wherein, Ra is each independently hydrogen (H), halo, C1-6 alkyl, C1-6 haloalkyl, C3-6 cycloalkyl, OH, —O—C1-6 alkyl, —O—C1-6 haloalkyl, —O—C3-6 cycloalkyl, —NH2, —NH—C1-6 alkyl, —NH—C1-6 haloalkyl, —NH—C3-6 cycloalkyl, —S—C1-6 alkyl, —S—C1-6 haloalkyl, —S—C3-6 cycloalkyl, —CN, or —NO2;
- m is 0, 1, 2, 3, or 4;
- any one of A1 and A2 is N, and the other is NR1, wherein R1 is H, OH, C1-6 alkyl, C1-6 haloalkyl, or C3-6 cycloalkyl;
- X is a bond, —(CH2)p—, —NR2—, —O—, or —S—, wherein p is 0 or 1, and R2 is H or C1-3 alkyl;
- Rb is each independently H, halo, C1-6 alkyl, C1-6 haloalkyl, C3-6 cycloalkyl, C2-6 alkenyl, C2-6 alkynyl, —(CH2)q—OR3, —(CH2)q—NR3R4, —(CH2)q—SR3, —(CH2)q—NO2, —(CH2)q—CONHOH, —(CH2)q—CN, —(CH2)q—COR3, —(CH2)q—CO2R3, —(CH2)q—CONR3R4, —(CH2)q-tetrazole, —(CH2)qCH═CH—CN, —(CH2)q—CH═CH—CO2R3, —(CH2)q—CH═CH—CONR3R4, —(CH2)q—CH═CH-tetrazole, —(CH2)q—NHCOR3, —(CH2)q—NHCO2R3, —(CH2)q—CONHSO2R3, —(CH2)q—NHSO2R3, —(CH2)q—C═C—CN, —(CH2)q—C═C—CO2R3, —(CH2)q—C═C—CONR3R4, —(CH2)q—C═C-tetrazole, —(CH2)q—SOR5, —(CH2)q—SO2R5, or —(CH2)r—(OR3)2, wherein R3 and R4 are each independently H, C1-6 alkyl, C1-6 haloalkyl, or C3-6 cycloalkyl, or taken together with a nitrogen atom bound thereto to form a mono-cyclic ring, for example, imidazole, pyrrolidine, piperidine, morpholine, piperazine, and homopiperazine, R5 is C1-6 alkyl, C1-6 haloalkyl, or C3-6 cycloalkyl, q is 0, 1, 2, 3, or 4, r is 1, 2, 3, or 4;
- and
- n is 0, 1, 2, 3, 4, or 5a.
4 more elements
Dependencies are inferred from the claim text.